PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Harrow Health, Inc. (HROW)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US4158581094

CUSIP

415858109

Sector

Healthcare

IPO Date

Sep 28, 2007

Highlights

Market Cap

$1.39B

EPS (TTM)

-$0.95

Total Revenue (TTM)

$169.14M

Gross Profit (TTM)

$122.73M

EBITDA (TTM)

-$2.47M

Year Range

$8.72 - $59.23

Target Price

$60.85

Short %

10.31%

Short Ratio

4.56

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
HROW vs. XLV HROW vs. UNH HROW vs. HALO HROW vs. CAVA HROW vs. UBER HROW vs. META
Popular comparisons:
HROW vs. XLV HROW vs. UNH HROW vs. HALO HROW vs. CAVA HROW vs. UBER HROW vs. META

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Harrow Health, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%200.00%250.00%JuneJulyAugustSeptemberOctoberNovember
140.76%
11.19%
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Returns By Period

Harrow Health, Inc. had a return of 254.46% year-to-date (YTD) and 319.66% in the last 12 months. Over the past 10 years, Harrow Health, Inc. had an annualized return of 16.93%, outperforming the S&P 500 benchmark which had an annualized return of 11.14%.


HROW

YTD

254.46%

1M

-30.93%

6M

140.75%

1Y

319.66%

5Y (annualized)

48.14%

10Y (annualized)

16.93%

^GSPC (Benchmark)

YTD

24.05%

1M

0.89%

6M

11.19%

1Y

30.12%

5Y (annualized)

13.82%

10Y (annualized)

11.14%

Monthly Returns

The table below presents the monthly returns of HROW, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-14.91%13.64%22.16%-22.98%76.15%16.38%23.41%56.94%11.12%0.22%254.46%
20231.76%19.31%18.08%19.23%-25.25%0.95%15.97%-31.30%-5.27%-0.21%-35.63%21.34%-24.12%
2022-13.19%2.80%-11.54%-0.73%6.79%0.69%-7.69%33.78%34.26%-0.33%-7.32%32.38%70.83%
202131.20%-14.78%-11.99%13.63%19.95%0.98%-3.98%18.83%-14.25%11.00%-0.89%-13.60%25.95%
2020-25.19%-5.15%-30.80%17.54%20.49%-3.70%5.18%25.73%-18.87%-14.85%20.80%19.30%-11.83%
20194.75%16.44%-28.24%-6.43%30.26%43.33%-10.92%-30.97%5.05%-11.03%25.00%24.48%36.73%
201810.00%-2.67%-3.30%29.55%-2.19%-1.35%6.82%29.36%-8.55%53.60%10.77%20.30%234.71%
2017-10.40%8.93%70.90%-2.40%-23.34%2.56%-19.38%-29.07%-12.02%-6.83%14.00%-0.58%-32.00%
2016-14.00%-31.54%-2.70%-0.50%-1.27%-3.59%2.93%7.75%-8.63%-29.40%1.12%-8.09%-63.92%
2015-1.73%1.76%6.53%1.00%5.33%-4.35%-3.20%-2.16%-16.62%21.34%-13.61%2.97%-7.60%
2014147.32%4.09%-22.43%5.07%-20.57%23.93%5.91%6.12%-4.87%15.90%-1.74%-11.24%123.21%
2013-15.38%-39.52%18.24%54.75%9.53%-15.20%-13.68%-17.62%-25.37%-8.22%0.48%-19.04%-65.54%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of HROW is 98, placing it in the top 2% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of HROW is 9898
Combined Rank
The Sharpe Ratio Rank of HROW is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of HROW is 9898
Sortino Ratio Rank
The Omega Ratio Rank of HROW is 9797
Omega Ratio Rank
The Calmar Ratio Rank of HROW is 9696
Calmar Ratio Rank
The Martin Ratio Rank of HROW is 9999
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for HROW, currently valued at 4.02, compared to the broader market-4.00-2.000.002.004.004.022.54
The chart of Sortino ratio for HROW, currently valued at 4.87, compared to the broader market-4.00-2.000.002.004.004.873.40
The chart of Omega ratio for HROW, currently valued at 1.62, compared to the broader market0.501.001.502.001.621.47
The chart of Calmar ratio for HROW, currently valued at 3.67, compared to the broader market0.002.004.006.003.673.66
The chart of Martin ratio for HROW, currently valued at 31.83, compared to the broader market-10.000.0010.0020.0030.0031.8316.28
HROW
^GSPC

The current Harrow Health, Inc. Sharpe ratio is 4.02. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Harrow Health, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00JuneJulyAugustSeptemberOctoberNovember
4.02
2.54
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Harrow Health, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-80.00%-60.00%-40.00%-20.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-71.23%
-1.41%
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Harrow Health, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Harrow Health, Inc. was 99.46%, occurring on Mar 19, 2012. The portfolio has not yet recovered.

The current Harrow Health, Inc. drawdown is 71.23%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.46%Oct 11, 20071118Mar 19, 2012

Volatility

Volatility Chart

The current Harrow Health, Inc. volatility is 25.94%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%JuneJulyAugustSeptemberOctoberNovember
25.94%
4.07%
HROW (Harrow Health, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Harrow Health, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Harrow Health, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items